Abstract
The time course of plasma drug levels and urinary recovery for two lipopeptide antifungal antibiotics, L-671,329 and cilofungin, were measured in male rhesus monkeys (Macaca mulatta) and in female DBA/2 mice. The antibiotics were administered intravenously at 10 mg/kg of body weight in phosphate-buffered saline-26% polyethylene glycol for the rhesus monkeys and in 5% dimethyl sulfoxide for the mice. Plasma and urine drug concentrations were determined by high-pressure liquid chromatography and/or a microbiological assay versus Aspergillus niger, and pharmacokinetic parameters were determined for both species. In each of the two rhesus crossover tests as well as in the mouse studies, the pharmacokinetics of the two compounds were similar; however, a marked difference was evident between species. The half-lives of L-671,329 and cilofungin in plasma were 39 and 34 min in the mice and averaged 1.8 and 2 h in the rhesus monkeys, respectively. In mice and rhesus monkeys, urinary recovery was less than 4% for both compounds.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Debono M., Abbott B. J., Fukuda D. S., Barnhart M., Willard K. E., Molloy R. M., Michel K. H., Turner J. R., Butler T. F., Hunt A. H. Synthesis of new analogs of echinocandin B by enzymatic deacylation and chemical reacylation of the echinocandin B peptide: synthesis of the antifungal agent cilofungin (LY121019). J Antibiot (Tokyo) 1989 Mar;42(3):389–397. doi: 10.7164/antibiotics.42.389. [DOI] [PubMed] [Google Scholar]
- Denning D. W., Stevens D. A. Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis. Antimicrob Agents Chemother. 1991 Jul;35(7):1329–1333. doi: 10.1128/aac.35.7.1329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gordee R. S., Zeckner D. J., Howard L. C., Alborn W. E., Jr, Debono M. Anti-Candida activity and toxicology of LY121019, a novel semisynthetic polypeptide antifungal antibiotic. Ann N Y Acad Sci. 1988;544:294–309. doi: 10.1111/j.1749-6632.1988.tb40415.x. [DOI] [PubMed] [Google Scholar]
- Lee J. W., Kelly P., Lecciones J., Coleman D., Gordee R., Pizzo P. A., Walsh T. J. Cilofungin (LY121019) shows nonlinear plasma pharmacokinetics and tissue penetration in rabbits. Antimicrob Agents Chemother. 1990 Nov;34(11):2240–2245. doi: 10.1128/aac.34.11.2240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pfeffer M. COMPT, a time-sharing program for nonlinear regression analysis of compartmental models of drug distribution. J Pharmacokinet Biopharm. 1973 Apr;1(2):137–163. doi: 10.1007/BF01059627. [DOI] [PubMed] [Google Scholar]
- Schwartz R. E., Giacobbe R. A., Bland J. A., Monaghan R. L. L-671,329, a new antifungal agent. I. Fermentation and isolation. J Antibiot (Tokyo) 1989 Feb;42(2):163–167. doi: 10.7164/antibiotics.42.163. [DOI] [PubMed] [Google Scholar]
- Swabb E. A., Bonner D. P. Prediction of aztreonam pharmacokinetics in humans based on data from animals. J Pharmacokinet Biopharm. 1983 Jun;11(3):215–223. doi: 10.1007/BF01061865. [DOI] [PubMed] [Google Scholar]
- Walsh T. J., Lee J. W., Kelly P., Bacher J., Lecciones J., Thomas V., Lyman C., Coleman D., Gordee R., Pizzo P. A. Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis. Antimicrob Agents Chemother. 1991 Jul;35(7):1321–1328. doi: 10.1128/aac.35.7.1321. [DOI] [PMC free article] [PubMed] [Google Scholar]